Concentrations of Formoterol in Blood and Urine

• Status: Unknown status
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of the study is to assess the blood and urine concentrations of inhaled formoterol.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bispebjerg Hospital
• Collaborator: Hormone Laboratory, Aker University Hospital, Oslo, Norway
• Treatments: Formoterol Fumarate

Criteria

Inclusion Criteria:

• Physician-diagnosed asthma with positive reversibility or challenge test.

• Informed consent.

• Age between 18-45 years.

• Sex: male.

• Asthma classified as mild to moderate according to GINA guidelines.

• Used beta-2-agonist in minimum 12 months.

Exclusion Criteria:

• Smokers or ex-smokers with a smoking history of 10 pack years or more.

• Respiratory tract infections within the last 2 weeks prior to study day.

• Subjects with other chronic diseases than asthma and allergy.

• Allergy towards the study medicine.

• Use of beta-2-agonist 10 days prior to study day.